Home Tags HER2

Tag: HER2

MI130004, a New ADC Using a Marine Compound, Shows Promising Therapeutic...

Over the last decade, antibody–drug conjugates or ADCs have emerged as powerful tool for the treatment of patients with cancer and hematological disorders.  These...

HER2+ Metastatic Breast Cancer and CNS metastases: A Retrospective, Exploratory Analysis...

The development of targeted antibody-drug conjugates (ADC) for the treatment of cancer represents a significant - and promising - progress. ADCs are precise and...

Second Generation HER2-antibody-drug conjugate Offers Best-in-Class Potential and Improved Therapeutic Index

In pre-clinical xenograft studies using patient-derived breast cancer and non-small-cell lung cancer material, Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported...

The Next Advancements in Cancer Drug Development: Antibody-Drug Conjugates

The annual meeting of the American Society of Clinical Oncology (ASCO) conference held June 1-5, 2012 in Chicago, IL offered a wealth of new...

X